Page last updated: 2024-08-21

vancomycin and me1036

vancomycin has been researched along with me1036 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atsumi, K; Iwamatsu, K; Kano, Y; Kurazono, M; Maruyama, T; Shitara, E; Yamamoto, Y1
Fritsche, TR; Jones, RN; Sader, HS1
Fisher, JF; Llarrull, LI; Mobashery, S1
Hirai, Y; Kijima, K; Kurazono, M; Nagura, J; Shitara, E; Sugano, T; Takahata, S; Takayama, Y; Tanaka, Y; Yamada, K; Yonezawa, M1
Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Kurihara, S; Morinaga, Y; Nakamura, S; Ohnishi, Y; Seki, M; Yamada, Y; Yamamoto, Y; Yanagihara, K1

Reviews

1 review(s) available for vancomycin and me1036

ArticleYear
Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactams; Cell Wall; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Peptide Synthases; Staphylococcus aureus

2009

Other Studies

4 other study(ies) available for vancomycin and me1036

ArticleYear
Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
    Bioorganic & medicinal chemistry, 2007, Jan-01, Volume: 15, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Haemophilus influenzae; Microbial Sensitivity Tests; Molecular Conformation; Pyridinium Compounds; Staphylococcus aureus; Stereoisomerism; Streptococcus pneumoniae; Structure-Activity Relationship

2007
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States

2008
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2005
Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Carbapenems; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia, Staphylococcal; Staphylococcus aureus; Tissue Distribution; Vancomycin; Vancomycin Resistance

2008